Completed NA INTERVENTIONAL 2-arm
NCT05069883
Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy
Sponsor: Armed Forces Institute of Urology, Rawalpindi
Conditions
Recurrence
Interventions
No steroid Steroid Drug
Updated 3 times since 2021 Last updated: Sep 26, 2021 Started: Jan 1, 2018 Primary completion: Mar 31, 2021 Completion: Mar 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Recurrence and is currently completed. Armed Forces Institute of Urology, Rawalpindi leads this study, which shows 3 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2021 — Jul 2024 [monthly]
Completed NA
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Armed Forces Institute of Urology, Rawalpindi
- Services Hospital, Lahore
Data source: Services Hospital, Lahore
For direct contact, visit the study record on ClinicalTrials.gov .